Medications for Opioid Use Disorder (MOUD)

active

URL

http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.269

Version

20240215

PublisherMathematicaDate2024-02-15T01:10:30-05:00Purpose

(Clinical Focus: The purpose of this value set is to group concepts that represent medications for opioid use disorders.),(Data Element Scope: This value set may use a model element related to medication.),(Inclusion Criteria: Includes concepts that represent medications used for opioid use disorders.),(Exclusion Criteria: No exclusions.)

Expansion

Code	Display	System
1597568		http://www.nlm.nih.gov/research/umls/rxnorm
904876		http://www.nlm.nih.gov/research/umls/rxnorm
1010604		http://www.nlm.nih.gov/research/umls/rxnorm
1307056		http://www.nlm.nih.gov/research/umls/rxnorm
1544851		http://www.nlm.nih.gov/research/umls/rxnorm
991147		http://www.nlm.nih.gov/research/umls/rxnorm
1431102		http://www.nlm.nih.gov/research/umls/rxnorm
637213		http://www.nlm.nih.gov/research/umls/rxnorm
1542997		http://www.nlm.nih.gov/research/umls/rxnorm
351264		http://www.nlm.nih.gov/research/umls/rxnorm
1010600		http://www.nlm.nih.gov/research/umls/rxnorm
904880		http://www.nlm.nih.gov/research/umls/rxnorm
904870		http://www.nlm.nih.gov/research/umls/rxnorm
864761		http://www.nlm.nih.gov/research/umls/rxnorm
351267		http://www.nlm.nih.gov/research/umls/rxnorm
864714		http://www.nlm.nih.gov/research/umls/rxnorm
1544854		http://www.nlm.nih.gov/research/umls/rxnorm
1597573		http://www.nlm.nih.gov/research/umls/rxnorm
1666338		http://www.nlm.nih.gov/research/umls/rxnorm
864718		http://www.nlm.nih.gov/research/umls/rxnorm

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 30
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2024-02-15T01:10:30-05:00",
  "meta" : {
    "versionId" : "9",
    "lastUpdated" : "2024-02-15T01:10:30.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "Mathematica",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to group concepts that represent medications for opioid use disorders.),(Data Element Scope: This value set may use a model element related to medication.),(Inclusion Criteria: Includes concepts that represent medications used for opioid use disorders.),(Exclusion Criteria: No exclusions.)",
  "name" : "MedicationsForOpioidUseDisorderMOUD",
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1010600",
      "display" : "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1010604",
      "display" : "buprenorphine 8 MG / naloxone 2 MG Sublingual Film",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1307056",
      "display" : "buprenorphine 4 MG / naloxone 1 MG Sublingual Film",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1307061",
      "display" : "buprenorphine 12 MG / naloxone 3 MG Sublingual Film",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1431076",
      "display" : "buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1431102",
      "display" : "buprenorphine 5.7 MG / naloxone 1.4 MG Sublingual Tablet",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1432969",
      "display" : "168 HR buprenorphine 0.015 MG/HR Transdermal System",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1542390",
      "display" : "buprenorphine 2.1 MG / naloxone 0.3 MG Buccal Film",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1542997",
      "display" : "168 HR buprenorphine 0.0075 MG/HR Transdermal System",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1544851",
      "display" : "buprenorphine 4.2 MG / naloxone 0.7 MG Buccal Film",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1544854",
      "display" : "buprenorphine 6.3 MG / naloxone 1 MG Buccal Film",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1597568",
      "display" : "buprenorphine 11.4 MG / naloxone 2.9 MG Sublingual Tablet",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1597573",
      "display" : "buprenorphine 8.6 MG / naloxone 2.1 MG Sublingual Tablet",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1666338",
      "display" : "buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "238129",
      "display" : "1 ML buprenorphine 0.3 MG/ML Injection",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "351264",
      "display" : "buprenorphine 2 MG Sublingual Tablet",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "351265",
      "display" : "buprenorphine 8 MG Sublingual Tablet",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "351266",
      "display" : "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "351267",
      "display" : "buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "637213",
      "display" : "naltrexone 380 MG Injection",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "864706",
      "display" : "methadone hydrochloride 10 MG Oral Tablet",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "864714",
      "display" : "methadone hydrochloride 10 MG/ML Injectable Solution",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "864718",
      "display" : "methadone hydrochloride 5 MG Oral Tablet",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "864761",
      "display" : "methadone hydrochloride 1 MG/ML Oral Solution",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "864769",
      "display" : "methadone hydrochloride 2 MG/ML Oral Solution",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "864978",
      "display" : "methadone hydrochloride 40 MG Tablet for Oral Suspension",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "904870",
      "display" : "168 HR buprenorphine 0.01 MG/HR Transdermal System",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "904876",
      "display" : "168 HR buprenorphine 0.02 MG/HR Transdermal System",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "904880",
      "display" : "168 HR buprenorphine 0.005 MG/HR Transdermal System",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "991147",
      "display" : "methadone hydrochloride 10 MG/ML Oral Solution",
      "version" : "04012024"
    } ],
    "total" : 30,
    "identifier" : "urn:uuid:35c07c4b-9ed3-4f27-b0c5-37054516cad7",
    "timestamp" : "2024-04-23T07:50:24-04:00"
  },
  "title" : "Medications for Opioid Use Disorder (MOUD)",
  "extension" : [ {
    "valueString" : "Lantana Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2024-02-15",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2024-02-15",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "99f34da5-0383-492e-ae9a-01b1f6d9ecf7",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.269",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113762.1.4.1046.269"
  } ],
  "version" : "20240215"
}